CVS Health announced the early results of its $1.77 billion maximum tender offer for multiple series of senior notes. As of December 13, 2024, significant portions of the notes have been tendered, with acceptance rates ranging from 14.56% to 70.61% across different series.The company has elected to accept for purchase and make payment for validly tendered notes on December 18, 2024, subject to acceptance priority levels. Due to reaching the maximum tender offer amount, no additional notes are expected to be purchased after the early settlement date.The total consideration for each $1,000 principal amount will be calculated to yield a sum equal to the applicable U.S. Treasury reference security yield plus a fixed spread. Holders of accepted notes will receive the total consideration, including a $30 per $1,000 early tender payment, plus accrued interest.

CVS Health announced the early results of its $1.77 billion maximum tender offer for multiple series of senior notes. As of December 13, 2024, significant portions of the notes have been tendered, with acceptance rates ranging from 14.56% to 70.61% across different series.The company has elected to accept for purchase and make payment for validly tendered notes on December 18, 2024, subject to acceptance priority levels. Due to reaching the maximum tender offer amount, no additional notes are expected to be purchased after the early settlement date.The total consideration for each $1,000 principal amount will be calculated to yield a sum equal to the applicable U.S. Treasury reference security yield plus a fixed spread. Holders of accepted notes will receive the total consideration, including a $30 per $1,000 early tender payment, plus accrued interest.